Chemical constituents from the aerial parts of Musella lasiocarpa by Liao-Bin Dong et al.
Regular Article                                                                                                                                     Nat. Prod. Bioprospect. 2011, 1, 41–47 
DOI 10.1007/s13659-011-0007-7 
 
         
Chemical constituents from the aerial parts of Musella lasiocarpa 
Liao-Bin DONG,a,b Juan HE,a Xing-Yao LI,a,b Xing-De WU,a,b Xu DENG,a,b Gang XU,a Li-Yan PENG,a Yu 
ZHAO,a Yan LI,a Xun GONG,a and Qin-Shi ZHAOa,* 
aState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Acad-
emy of Sciences, Kunming 650201, China 
bGraduate University of Chinese Academy of Sciences, Beijing 100039, China 
 
Received 3 July 2011; Accepted 26 August 2011  
© The Author(s) 2011. This article is published with open access at Springerlink.com 
 
Abstract: Phytochemical investigation of the aerial parts of the monotypic plant, Musella lasiocarpa, led to the isolation of four 
rare bicyclic diarylheptanoids, musellarins BE (25), two new phenylphenalenones, 2-methoxy-9-(3′,4′-dihydroxyphenyl)-1H-
phenalen-1-one (9), 2-methoxy-9-(3′-methoxy-4′-hydroxyphenyl)-1H-phenalen-1-one (10), a new acenaphtylene derivative, trans-
(1S,2S)-3-(4′-methoxyphenyl)-acenaphthene-1,2-diol (13), and two new sucrose esters, 1,2′,3′,4′,6′-O-pentaacetyl-3-O-trans-p-
coumaroylsucrose (16), 1,2′,3′,4′,6′-O-pentaacetyl-3-O-cis-p-coumaroylsucrose (17), together with nine known compounds. In addi-
tion, (4E,6E)-1-(3′,4′-dihydroxyphenyl)-7-(4′′-hydroxyphenyl)-hepta-4,6-dien-3-one (15) was isolated for the first time from a natu-
ral source. The structures of new compounds were elucidated by analysis of their spectroscopic data. Compounds 2, 6, 810, 12, 
and 14 were cytotoxic toward several of the human tumor cell lines (HL-60, SMMC-7721, A-549, MCF-7, and SW480). Of these, 
the new compound 9 was the most potent one, with IC50 values of 5.8, 10.3, 6.3, 3.3, and 2.3 µM, respectively. 
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Introduction 
Musella lasiocarpa (Musaceae) is a monotypic species, 
which is distributed in the conifer-oak mixed forests at 1500-
2500 m and endemic to the area from the middle to the west of 
Yunnan Province in China.1 Due to its strongly yellow-colored 
spherical flowers, the plant was used as an ornamental in some 
Asian countries. Moreover, M. lasiocarpa has been used as a 
folk remedy for treatment of some gynaecological diseases, 
such as metrorrhagia and leucorrhoea, bleeding, enteritis, con-
stipation, monkshood (Aconitum spp.) poisoning, drunkenness, 
etc.1,2 Previous studies on this plant have resulted in the isola-
tion of four phenylphenalenones,3 the characteristic com-
pounds of the family Musaceae, an amide,4 a lactone,4 and 
several other compounds.5 In addition, several of the com-
pounds exhibited antibacteria and cytotoxic activities.3,4 In the 
course of our systematic search for bioactive compounds from 
the monotypic species endemic in China,6 four rare bicyclic 
diarylheptanoids (25), two new phenylphenalenones (9 and 
10), a new acenaphtylene derivative (13), and two new sucrose 
esters (16 and 17), together with nine known compounds were 
isolated from the title plant. Except for 13, 16, and 17, the 
other compounds were evaluated for cytotoxicity against five 
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and SW480). Herein, we report the isolation, structural eluci-
dation, and cytotoxicity of the compounds obtained in this 
investigation. 
 
Results and Discussion 
Compound 2 was isolated as a white, amorphous powder. 
The molecular formula C21H22O5 was established on the basis 
of HREIMS (m/z 354.1461 [M]+, calcd for 354.1467). The IR 
spectrum showed the presence of hydroxyl (3424 cm-1) and 
aromatic (1611 and 1512 cm−1) functionalities. The 1H NMR 
spectrum (Table 1) revealed signals of a 1,3,4-trisubstituted 
aromatic ring [δH 7.01 (1H, br s, H-2′), 6.80 (1H, d, J = 8.0 Hz, 
H-5′), and 6.86 (1H, br d, J = 8.0 Hz, H-6′)], a 1,2,4,5-
tetrasubstituted aromatic ring [δH 6.54 (1H, s, H-7), 6.89 (1H, 
s, H-10)], two aromatic methoxy groups [δH 3.82 (3H, s), 3.84 
(3H, s)], two olefinic protons [δH 6.28 (1H, ddd, J = 10.2, 4.0, 
2.0 Hz, H-1), 5.90 (1H, dt, J = 10.2, 2.0 Hz, H-2)], two oxy-
genated methine protons [δH 5.05 (1H, br s, H-3), 4.14 (1H, m, 
H-4a)], and four methylene protons [δH 1.79 (1H, m, H-5α), 
2.03 (1H, m, H-5β), 2.55 (1H, m, H-6α), and 2.85 (1H, m, H-
6β)]. The above moieties were further confirmed by the 13C 
NMR data (Table 2) and DEPT experiments. Correlations in 
the 1H–1H COSY and HSQC spectra revealed the presence of 
a CH2(6)CH2(5)CH(4a)CH(10b) CH(1)=CH(2)CH(3) 
unit (Figure 1). The HMBC correlations from H-3 at δH 5.05 
(1H, br s) to C-4a (δC 68.1, d), C-2′ (δC 112.1, d), and C-6′ (δC 
121.3, d) suggested the presence of a tetrahydropyran unit 
bearing an aromatic ring connected to C-3. Furthermore, in the 
HMBC spectrum the correlations from H-7 at δH 6.54 (1H, s) 
to C-6 (δC 26.2, t), and H-10 at δH 6.89 (1H, s) to C-10b (δC 
37.5, d) indicated the existence of a 1,2,3,4-
tetrahydronaphthalene group. The two methoxy groups were 
located at C-9 and C-3′ as evidenced by the HMBC correla-
tions of OCH3/C-9 and OCH3/C-3′, and the ROESY correla-
tions of OCH3/H-10 and OCH3/H-2′. 
The relative configuration of compound 2 was determined 
on the basis of a ROESY experiment (Figure 1). The ROESY 
correlations of H-4a/H-10b, H-4a/H-2′ and H-6′, H-4a/H-6α, 
and H-10b/H-5α, indicated that these protons were cofacial 
and assigned as α-oriented.7 In consequence, the ROESY 
cross-peak of H-3/H-5β demonstrated that they were β-
oriented. Thus, compound 2 was elucidated as rel-
(3S,4aR,10bR)-3-(3′-methoxy-4′-hydroxyphenyl)-8-hydroxy-9 
-methoxy-4a,5,6,10b-tetrahydro-3H-naphtho[2,1-b]pyran, and 
named as musellarin B. 
Compounds 3 and 4 had the same molecular weight [3, 
HREIMS m/z 354.1471 [M]+, C21H22O5; 4, HREIMS m/z 
354.1470 [M]+, C21H22O5] and their NMR spectroscopic data 
(Tables 1 and 2) indicated that their structures were closely 
related to 2. Compared to 2, one apparent change in 3 was the 
different position of the methoxy group at the 1,3,4-
trisubstituted aromatic ring. The strong cross-peaks in the 
HMBC (OCH3-4′/C-4′ and H-6′/C-4′) and ROESY (OCH3-
4′/H-5′) spectra of 3 indicated that the methoxy group was 
placed at C-4′. The difference between 4 and 2 was the relative 
configuration of H-4a, which was determined by the ROESY 
correlation of H-4a/H-3 in 4. Therefore, compound 3 was 
identified as rel-(3S,4aR,10bR)-3-(3′-hydroxy-4′-
methoxyphenyl)-8-hydroxy-9-methoxy-4a,5,6,10b-tetrahydro-
3H-naphtho[2,1-b]pyran, and named as musellarin C, while 
the structure rel-(3S,4aS,10bR)-3-(3′-methoxy-4′-
hydroxyphenyl)-8-hydroxy-9-methoxy-4a,5,6,10b-tetrahydro-
3H-naphtho[2,1-b]pyran was proposed for musellarin D (4). 
Compound 5, a white, amorphous powder, gave an [M]+ 
peak at m/z 324.1367 (C20H20O4) in the HREIMS, 30 mass 
units less than that of 4. According to the 1D NMR data (Ta-

















Figure 1.  Selected 2D NMR correlations observed for 2. 
Table 1.1H NMR spectroscopic data of compounds 25a in CD3OD (J in Hz). 
Pos. 2bc 3d 4c 5d 
1 6.28, ddd (10.2, 4.0, 2.0) 6.26, ddd (10.2, 4.0, 2.0) 6.45, ddd (10.0, 6.4, 1.8) 6.42, ddd (10.0, 6.0, 1.8) 
2 5.90, dt (10.2, 2.0) 5.87, dt (10.2, 2.0) 5.73, br d (10.0) 5.74, dt (10.0, 1.8) 
3 5.05, br s 5.05, d (1.5) 5.13, d (1.9) 5.11, br s 
4a 4.14, m 4.18, m 4.23, dd (5.6, 3.2) 4.22, dd (6.8, 3.8) 
5 1.79, m (α); 2.03, m (β) 1.84, m (α); 2.05, m (β) 1.90, m (α); 2.07, m (β) 1.87, m(α); 2.04, m (β) 
6 2.55, m (α); 2.85, m (β) 2.58, m (α); 2.84, m (β) 2.49, ddd (16.6, 5.6, 2.4, α) 
2.96, ddd (16.6, 12.8, 4.8, β) 
2.43, ddd (16.0, 5.5, 3.0, α) 
2.93, ddd (16.0, 12.5, 4.5, β) 
7 6.54, s 6.52, s 6.56, s 6.54, s 
10 6.89, s 6.83, s 6.87, s 6.86, s 
10b 3.36, br s 3.41, br s 3.27, br s 3.25, br s 
2′ 7.01, br s 6.89, overlap 6.52, d (1.2) 6.96, d (8.5) 
3′   6.64, d (8.5) 
5′ 6.80, d (8.0) 6.90, overlap 6.64, overlap 6.64, d (8.5) 
6′ 6.86, br d (8.0) 6.85, dd (8.0, 1.5) 6.63, overlap 6.96, d (8.5) 
9-OCH3 3.82, s 3.84, s 3.82, s 3.83, s 
3′-OCH3 3.84, s  3.50, s  
4′-OCH3  3.85, s   
aAssignments are based on 1D and 2D NMR experiments. b in CD3COCD3. c 400 MHz. d 500 MHz 
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of 4 in which the methoxy group at C-3′ was replaced by a 
hydrogen. Detailed analysis of 2D NMR spectra indicated that 
the other parts of 5 were the same as those of 4. Thus, com-
pound 5 was determined as rel-(3S,4aS,10bR)-3-(4′-
hydroxyphenyl)-8-hydroxy-9-methoxy-4a,5,6,10b-tetrahydro-
3H-naphtho[2,1-b]pyran, and named as musellarin E. 
The HREIMS of compound 9 showed a protonated molecu-
lar ion at m/z 318.0883 [M]+, corresponding to molecular for-
mula C20H14O4 with 14 degrees of unsaturation. Analysis of 
the 1H NMR spectrum (Table 3) indicated the existence of a 
2,4- or 2,9-substituted phenalen-1-one, a 1,3,4-trisubstituted 
benzene, and a methoxy moieties, which suggested that 9 was 
a phenylphenalen-1-one derivative substituted at C-4 or C-9 
with a 1,3,4-trisubstituted aromatic ring. Moreover, in the 
mass spectrum, 9 exhibited higher intensity of the [M − H]+ 
ion at m/z 317 than that of the [M]+ ion at m/z 318 (Supporting 
Information), supporting that the side chain was located at C-
9.8 This conclusion was also supported by the cross peak (H-
3/H-4) in ROESY spectrum. The correlations of -OCH3/C-2 in 
HMBC spectrum and -OCH3/H-3 in ROESY spectrum sug-
gested the methoxy group was connected to C-2. Thus, comp 
ound 9 was established as 2-methoxy-9-(3′,4′-
dihydroxyphenyl)-1H-phenalen-1-one. 
Compound 10 had an [M]+ peak at m/z 332.1046 (C21H16O4), 
14 mass units higher than that of 9. Analysis of its 1D NMR 
spectra (Table 3) indicated that 10 was a structural analogue of 
9, the only difference in 10 being the replacement of the hy-
droxyl group at C-3′ with a methoxy group. This was deter-
mined by the correlation of –OCH3/H-2′ in ROESY spectrum. 
Therefore, compound 10 was established as 2-methoxy-9-(3′-
methoxy-4′-hydroxyphenyl)-1H-phenalen-1-one. 
Compound 13 had the molecular formula C19H16O3 based on 
HRESIMS ([M + Na]+ m/z 315.0990; calcd for C19H16O3Na, 
315.0997). The 1H NMR spectrum (Table 3) exhibited nine 
aromatic protons corresponding to three systems (AMX, AB, 
and A2B2 system) of three benzene rings. The 13C NMR spec-
trum showed 19 signals, including 16 aromatic carbons, a 
methoxy group at δC 55.8, and two oxygenated carbons at δC 
84.0 and 83.1. The above data were very similar to those of 3-
phenyl-1,2-dihydroacenaphtylen-1,2-diol.9 Analysis of the 1D 
NMR spectra of the two compounds revealed that marked 
differences were the trans configuration of H-1 and H-2 as 
well as one more methoxy group located at C-4′ in 13. These 
were confirmed by the small coupling constant (J = 0 Hz) of 
H-1 and H-2,9,10 and the HMBC correlation of δH 3.86 (s, 
OCH3-4′) with δC 160.6 (s, C-4′). Due to the small amounts 
obtained (1.0 mg), the absolute configuration of 13 could not 
be determined through the method of exiton-coupled circular 
dichroism (ECCD).11 However, the specific rotation ([α] 20D 
22.7) value of 13 was similar to those of trans-(1S,2S)-
acenaphthene-1,2-diol ([α]20D 24.1)11 and opposite to those of 
Table 2. 13C NMR spectroscopic data of compounds 25a in CD3OD. 
Pos. 2bc 3c 4c 5d
1 129.8, CH 130.2, CH 128.3, CH 128.5, CH
2 128.5, CH 128.4, CH 131.6, CH 131.5, CH 
3 73.0, CH 73.7, CH 78.4, CH 78.4, CH 
4a 68.1, CH 69.6, CH 72.0, CH 72.5, CH 
5 27.2, CH2 27.3, CH2 29.3, CH2 29.6, CH2 
6 26.2, CH2 26.8, CH2 24.8, CH2 24.8, CH2 
6a 129.4, C 129.8, C 129.7, C 129.9, C 
7 115.4, CH 115.9, CH 116.0, CH 116.1, CH 
8 145.5, C 145.6, C 145.4, C 145.3, C 
9 147.0, C 147.8, C 147.6, C 147.6, C 
10 112.4, CH 112.7, CH 112.6, CH 112.5, C
10a 129.4, C 129.7, C 130.3, C 129.9, C 
10b 37.5, CH 38.1, CH 37.6, CH 37.5, CH 
1′ 133.8, C 135.1, C 134.8, C 134.0, C 
2′ 112.1, CH 116.1, CH 111.4, CH 129.5, CH 
3′ 148.1, C 147.5, C 148.9, C 116.0, CH 
4′ 147.0, C 148.8, C 147.1, C 158.1, C 
5′ 115.3, CH 112.4, CH 115.5, CH 116.0, CH 
6′ 121.3, CH 120.5, CH 120.7, CH 129.5, CH 
9-OCH3 56.3, CH3 56.5, CH3 56.5, CH3 56.6, CH3 
3′-OCH3 56.2, CH3  55.9, CH3  
4′-OCH3 56.4, CH3  
aAssignments are based on 1D and 2D NMR experiments. bin 
CD3COCD3. c100 MHz. d125 MHz. 
Table 3. 13C NMR and 1H NMR spectroscopic data of compounds 9a, 10a, 13a in CD3OD. 
 9  10  13 
Pos. δCb δH (J in Hz)d δCc δH (J in Hz)d Pos. δCc δH (J in Hz)e 
1 181.8, C  181.8, C  1 84.0, CH 5.30, br s 
2 154.6, C  154.6, C  2 83.1, CH 5.48, br s 
3 113.4, CH 7.14, s 113.6, CH 7.12, s 2a 139.5, C  
3a 126.4, C  126.5, C  3 136.9, C  
4 131.5, CH 7.82, d (7.2) 131.5, CH 7.79, d (7.2) 4 131.1, CH 7.65, d (8.5) 
5 127.9, CH 7.61, t (7.5) 127.9, CH 7.60, overlap 5 126.8, CH 7.86, d (8.5) 
6 130.8, CH 7.98, d (8.4) 130.7, CH 7.97, d (8.4) 5a 131.6, C  
6a 132.6, C  132.7, C  6 125.7, CH 7.80, dd (6.8, 1.8) 
7 136.0, CH 8.24, d (8.4) 136.1, CH 8.23, d (7.8) 7 122.4, CH 7.56, overlap 
8 133.0, CH 7.59, d (8.4) 132.9, CH 7.59, overlap 8 128.9, CH 7.57, overlap 
9 150.5, C  150.2, C  8a 144.0, C  
9a 126.4, C  126.5, C  8b 138.8, C  
9b 129.6, C  129.6, C  1′ 133.8, C  
1′ 135.8, C  135.8, C  2′/6′ 131.1, CH 7.74, d (8.5) 
2′ 116.7, CH 6.80, d (1.8) 113.5, CH 6.93, d (1.8) 3′/5′ 115.0, CH 7.04, d (8.5) 
3′ 146.2, C  148.9, C  4′ 160.6, C  
4′ 146.2, C  147.4, C  4′-OCH3 55.8, CH3 3.86, s 
5′ 116.3, CH 6.84, d (7.8) 116.3, CH 6.87, d (7.8)    
6′ 120.9, CH 6.69, dd (7.8, 1.8) 122.1, CH 6.80, dd (7.8, 1.8)    
2-OCH3 56.1, CH3 3.88, s 56.1, CH3 3.88, s    
3′-OCH3   56.6, CH3 3.84, s    
aAssignments are based on 1D and 2D NMR experiments. b150 MHz. c125 MHz. d600 MHz. e500 MHz. 
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trans-(1R,2R)-acenaphthene-1,2-diol ([α] 20D  +33.2),12 suggest-
ing that the absolute configuration of 13 should be (1S,2S). 
Thus, compound 13 was deduced as trans-(1S,2S)-3-(4′-
methoxyphenyl)-acenaphthene-1,2-diol. 
Compound 16 was obtained as a colorless, amorphous pow-
der. Its molecular formula was determined to be C31H38O18 by 
HRESIMS. The UV and IR spectra showed absorption bands 
for hydroxyl, α,β-unsaturated carbonyl ester, and aromatic ring 
functionalities. The 1H NMR (Table 4) spectrum revealed that 
16 possessed a trans-p-coumaroyl unit [δH 7.54 (2H, d, J = 8.4 
Hz, H-2′′/6′′), 6.20 (2H, d, J = 8.4 Hz, H-3′′/5′′), 6.44 (1H, d, J 
= 16.0 Hz, H-7′′), and 7.75 (1H, d, J = 16.0 Hz, H-8′′)], 14 
oxygenated protons (δH 3.795.69), and five alcoholic acetyl 
groups (δH 1.842.10). In the 13C NMR spectrum, the signals 
of the anomeric carbons [δC 103.8 (s, C-2), and 90.5 (d, C-1′)] 
indicated that the disaccharide moiety was sucrose.13 There-
fore, 16 was determined as a penta-acetylated derivative of 
trans-p-coumaroylsucrose. In the HMBC spectrum, the corre-
lation networks of H-3/C-9′′ (δC 168.1), H-1/OAc-1 (δC 172.0), 
H-2′/OAc-2′ (δC 171.8), H-3′/OAc-3′ (δC 171.5), H-4′/OAc-4′ 
(δC 171.3), and H-6′/OAc-6′ (δC 172.4) suggested the trans-p-
coumaroyl moiety was linked to C-3 and the five alcoholic 
acetyl groups were located at C-1, C-2′, C-3′, C-4′, and C-6′, 
respectively. Moreover, alkaline hydrolysis of 16 with 0.5% 
NaOH in MeOH yielded sucrose (Experimental Section). Ac-
cordingly, compound 16 was assigned as 1,2′,3′,4′,6′-O-
pentaacetyl-3-O-trans-p-coumaroylsucrose. 
Compound 17, a colorless, amorphous powder, gave a mo-
lecular formula of C31H38O18, as determined on the basis of an 
HRESIMS ion at m/z 697.1980 [M − H]− (calcd for C31H37O18, 
697.1979). Its 1H NMR spectrum (Table 4) was similar to 
those of 16, except for the existence of a cis-p-coumaroyl unit 
[δH 7.68 (2H, d, J = 8.4 Hz, H-2′′/6′′), 6.78 (2H, d, J = 8.4 Hz, 
H-3′′/5′′), 5.90 (1H, d, J = 12.8 Hz, H-7′′), and 7.00 (1H, d, J = 
12.8 Hz, H-8′′)] replacing the trans-p-coumaroyl moiety of 16. 
Therefore, the structure of 17 was characterized as 1,2′,3′,4′,6′-
O-pentaacetyl-3-O-cis-p-coumaroylsucrose. 
Hitherto, except for musellarins BE (25), only two bicy-
clic diarylheptanoids were isolated from the natural kingdom, 
whose names were rel-(3S,4aR,10bR)-3-(4′-hydroxyphenyl)-8-
hydroxy-9-methoxy-4a,5,6,10b-tetrahydro-3H-naphtho[2,1b] 
pyran (1, musellarin A),7 and 3-(4′-hydroxyphenyl)-
4a,5,6,10b-tetrahydro-1H-naphtho[2,1-b]pyran-1-one.14 In 
addition, compound 13 was the second acenaphtylene deriva-
tive isolated from plants. 
The known compounds were identified by comparison of 
their spectroscopic data with published values, as rel-
(3S,4aR,10bR)-3-(4′-hydroxyphenyl)-8-hydroxy-9-methoxy-4a, 
5,6,10b-tetrahydro-3H-naphtho[2,1-b]pyran (1, musellarin 
A),7 2-hydroxy-9-(4′-hydroxyphenyl)-1H-phenalen-1-one (6, 
hydroxyanigorufone),15 2-methoxy-9-(4′-hydroxyphenyl)-1H-
phenalen-1-one (7),8 2-hydroxy-9-(3′,4′-dihydroxyphenyl)-1H-





Table 4. 13C NMR and 1H NMR spectroscopic data of compounds 16a, 17a in CD3OD. 
 16  17
Pos. δCb δH (J in Hz)c  δCb δH (J in Hz)c 
1 66.3, CH2 4.23, d (11.6); 4.11, d (11.6) 66.0, CH2 4.17, d (11.4); 4.11, d (11.4) 
2 103.8, C  103.8, C  
3 79.8, CH 5.39, d (8.1) 79.2, CH 5.39, d (8.1) 
4 73.8, CH 4.32, t (8.1) 73.3, CH 4.26, t (8.1) 
5 84.5, CH 3.94, m 84.3, CH 3.90, m 
6 63.3, CH2 3.79, overlap 63.2, CH2 3.77, overlap 
1′ 90.5, CH 5.69, d (3.6) 90.5, CH 5.66, d (3.6) 
2′ 71.5, CH 4.87, overlap 71.6, CH 4.87, overlap
3′ 71.2, CH 5.39, t (9.8) 71.3, CH 5.35, t (9.8) 
4′ 69.9, CH 4.99, t (9.8) 69.8, CH 5.00, t (9.8) 
5′ 69.7, CH 4.35, m 69.6, CH 4.17, overlap 
6′ 63.5, CH2 4.18, overlap 63.3, CH2 4.17, overlap; 4.07, overlap 
1′′ 127.1, C  127.4, C  
2′′/6′′ 131.6, CH 7.54, d (8.4) 134.0, CH 7.68, d (8.4) 
3′′/5′′ 116.8, CH 6.20, d (8.4) 115.9, CH 6.78, d (8.4) 
4′′ 161.5, C  160.4, CH  
7′′ 147.9, CH 7.75, d (16.0) 146.7, C 7.00, d (12.8) 
8′′ 114.2, CH 6.44, d (16.0) 115.4, CH 5.90, d (12.8) 
9′′ 168.1, C  168.4, C  
OAc-1 172.0, C; 20.6, CH3 2.10, s 172.1, C; 20.6, CH3 2.09, s 
OAc-2′ 171.8 C; 20.7, CH3 2.04, s 171.8, C 20.7, CH3 2.03, s 
OAc-3′ 171.5, C; 20.5, CH3 1.94, s 171.6, C 20.6, CH3 1.96, s 
OAc-4′ 171.3, C; 20.4, CH3 1.84, s 171.3, C 20.7, CH3 2.01, s
OAc-6′ 172.4, C; 20.7, CH3 2.06, s 172.4, C 20.6, CH3 2.06, s 
aAssignments are based on 1D and 2D NMR experiments. b100 MHz. c400 MHz.
Table 5. Cytotoxicity of 2, 6, 810, 12, and 14 against tumor 
cell linesa with IC50 (μM). 
Compound HL-60 SMMC-7721 A-549 MCF-
7 
SW480
2 21.3 26.7 25.1 > 40 > 40 
6 18.2 39.4 23.9 > 40 > 40
8 8.8 >40 > 40 27.3 28.4 
9 5.8 10.3 6.3 3.3 2.3 
10 12.1 21.3 > 40 22.9 19.9 
12 > 40 > 40 > 40 33.1 37.5 
14 6.4 > 40 35.2 > 40 > 40 
cisplatinb 1.0 17.0 16.0 17.1 19.1 
aCell lines: HL-60 acute leukemia; SMMC-7721 liver cancer; A-
549 lung cancer; MCF-7 breast cancer; SW480 colon cancer. bposi-
tive control.
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3-one (15),19 and 2-(4′-hydroxyphenyl)-1,8-naphthalic anhy-
dride.20  
Previously, a number of phenylphenalenones with moderate 
cytotoxic effects against P388 murine leukemia cell line were 
reported from Haemodorum simplex.21 In this study, except for 
13, 16, and 17, the other compounds were evaluated for cyto-
toxicity against five human tumor cell lines (HL-60, SMMC-
7721, A-549, MCF-7, and SW480) using the MTT method.22 
Cisplation was used as the positive control. Of these com-
pounds, 2, 6, 810, 12, and 14 were found to be active princi-
ples, and their cytotoxic activities were summarized in Table 5. 
The new compound 9 was the most cytotoxic against all of the 




General Experimental Procedures. Optical rotations were 
measured on a JASCO-20C digital polarimeter. IR spectra 
were obtained on a Tensor 27 spectrometer with KBr pellets. 
UV spectra were recorded using a Shimadzu UV-2401A spec-
trophotometer. 1D and 2D NMR spectra were performed on a 
Bruker AM-400, DRX-500 or AV III-600 spectrometers with 
TMS as an internal standard. Mass spectra were obtained on a 
VG Auto Spec-3000 or API-Qstar-Pulsar instrument. For su-
crose, the ESIMS was taken on a Bruker Esquire HCT 3D ion 
trap mass spectrometer (ESI mode). Semipreparative HPLC 
was performed on an Agilent 1100 liquid chromatography 
with a Zorbax SB-C18 (9.4 mm × 25 cm) column. Column 
chromatography (CC) was performed using silica gel 
(200300 mesh, Qingdao Marine Chemical Co. Ltd., Qingdao, 
People’s Republic of China), MCI gel (75150 μm; Mitsubishi 
Chemical Corporation, Japan), and Sephadex LH-20 (Amer-
sham Pharmacia Biotech, Sweden). 
 
Plant Materials. Plants of M. lasiocarpa were collected in 
the Kunming Botany Garden, Kunming, Yunnan Province, 
China, in September 2009, and were identified by one of the 
authors (Xun Gong). A voucher specimen (200909M) was 
deposited at the State Key Laboratory of Phytochemistry and 
Plant Resources in West China, Kunming Institute of Botany, 
Chinese Academy of Sciences. 
 
Extraction and Isolation. The air-dried and powdered aeri-
al parts of M. lasiocarpa (3.0 kg) were extracted with MeOH 
(4 × 10 L), each for 48 h, at room temperature and, concentrat-
ed in vacuo to give a crude extract. The extract was partitioned 
between H2O and EtOAc. The EtOAc portion (73.8 g) was 
decolorized on MCI gel (eluted with 90% MeOH) and then 
was chromatographed on MPLC (MCI gel) eluting with a gra-
dient of MeOHH2O (3:7, 6:4, 9:1, and 1:0) to afford four 
fractions (F01–F04). Fraction F03 (23.5 g) was fractionated by 
MPLC (MCI gel) again, eluted with MeOH-H2O (from 40% to 
100%) to provide subfractions (F0301F0305). Subfraction 
F0301 (800 mg) was chromatographed over silica gel CC, 
using CHCl3-MeOH (20:1) as solvent, and then purified over 
Sephadex LH-20 eluted with MeOH, then by semipreparative 
HPLC (29% MeCNH2O) to give 16 (tR 21.8 min, 12 mg) and 
17 (tR 24.7 min, 5 mg). Subfraction F0302 (1.0 g) was chro-
matographed over Sephadex LH-20 eluting with MeOH, and 
then purified repeatedly over silica gel CC, then by semipre-
parative HPLC (52% MeOHH2O) to give 15 (tR 20.4 min, 3 
mg). Subfraction F0303 (1.84 g) was further chromatographed 
on silica gel CC, eluted with a gradient of CHCl3-MeOH 
(150:1→0:1) to afford six subfractions F030301–F030306. 
Subfraction F030301 (94 mg) was purified on Sephadex LH-
20 eluting with MeOH, and then chromatographed by semi-
preparative HPLC (52% MeOHH2O) to furnish 2 (tR 13.8 
min, 3 mg), 3 (tR 17.1 min, 2 mg), and 4 (tR 22.4 min, 2 mg). 
Subfraction F030302 (136 mg) was chromatographed repeat-
edly over silica gel CC eluted with petroleum ether-acetone 
(10:1) to afford 2-(4′-hydroxyphenyl)-1,8-naphthalic anhy-
dride (18 mg). Subfraction F030303 (240 mg) was chromato-
graphed over a Sephadex LH-20 column, using MeOH as sol-
vent, and then purified by semipreparative HPLC (55% 
MeOHH2O) to yield 13 (tR 10.8 min, 1 mg). Another peak 
with a retention time of 16.0 min was collected and further 
purified by preparative TLC eluted with petroleum ether-
EtOAc (6:4) to furnish 1 (18 mg) and 5 (2 mg). Compound 8 
(5 mg) and 11 (3 mg) were isolated from subfraction F030304 
(110 mg) by preparative TLC, using tolueneEtOAcformic 
acid (8:2:1) as solvent. Subfraction F030305 (75 mg) was pu-
rified by semipreparative HPLC (52% MeOHH2O) to yield 
14 (tR 18.0 min, 15 mg). Subfraction F030306 (180 mg) was 
submitted to repeated silica gel CC, and then chromatographed 
by semipreparative HPLC (59% MeOHH2O) to afford 9 (tR 
15.1 min, 5 mg). Subfraction F0304 (1.95 g) was subjected to 
passage over a silica gel column, eluted with a gradient of 
CHCl3-MeOH (150:1→0:1) to afford five fractions F030401–
F030405. Subfraction F030402 (140 mg) was purified by sem-
ipreparative HPLC (54% MeOHH2O) to give 10 (tR 26.2 min, 
2 mg). Subfraction F030403 (145 mg) was chromatographed 
by semipreparative HPLC (60% MeOHH2O) to yield 6 (tR 
13.5 min, 50 mg). Subfraction F030404 was separated by a 
silica gel column, using petroleum ether-acetone (8:2) as sol-
vent system, then purified by Sephadex LH-20 eluted with 
MeOH to afford 7 (2 mg) and 12 (4 mg). 
 
Musellarin B (2): white, amorphous powder; [α]20D − 223.3 
(c 0.17, MeOH); UV (MeOH) λmax (log ε) 284 (3.63), 205 
(4.51) nm; IR (KBr) νmax 3424, 2931, 1611, 1512, 1450, 1272, 
1113, 777 cm−1; 1H and 13C NMR data, see Tables 1 and 2; 
positive EIMS m/z 354 [M]+; positive HREIMS m/z 354.1461 
[M]+ (calcd for C21H22O5, 354.1467). 
 
Musellarin C (3): white, amorphous powder; [α]20D − 176.8 
(c 0.30, MeOH); UV (MeOH) λmax (log ε) 284 (3.53), 206 
(4.42) nm; IR (KBr) νmax 3425, 2929, 1598, 1510, 1441, 1384, 
1273, 1126, 790 cm−1; 1H and 13C NMR data, see Tables 1 and 
2; positive EIMS m/z 354 [M]+; positive HREIMS m/z 
354.1471 [M]+ (calcd for C21H22O5, 354.1467). 
 
Musellarin D (4): white, amorphous powder; [α]20D − 41.9 (c 
0.29, MeOH); UV (MeOH) λmax (log ε) 284 (3.26), 205 (4.21) 
nm; IR (KBr) νmax 3431, 2929, 1629, 1514, 1451, 1277, 1114, 
778 cm−1; 1H and 13C NMR data, see Tables 1 and 2; positive 
EIMS m/z 354 [M]+; positive HREIMS m/z 354.1470 [M]+ 
(calcd for C21H22O5, 354.1467). 
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Musellarin E (5): white, amorphous powder; [α]20D − 111.5 
(c 0.19, MeOH); UV (MeOH) λmax (log ε) 284 (3.31), 225 
(3.84), 205 (4.23) nm; IR (KBr) νmax 3423, 2927, 1614, 1514, 
1446, 1256, 1115, 834 cm−1; 1H and 13C NMR data, see Tables 
1 and 2; positive EIMS m/z 324 [M]+; positive HREIMS m/z 
324.1367 [M]+ (calcd for C20H20O4, 324.1362). 
 
2-Methoxy-9-(3′,4′-dihydroxyphenyl)-1H-phenalen-1-
one (9): red powder; UV (MeOH) λmax ( log ε) 412 (3.25), 366 
(3.27), 268 (3.63), 263 (3.63), 205 (4.02) nm; IR (KBr) νmax 
3430, 1627, 1276 cm−1; 1H and 13C NMR data, see Table 3; 
positive EIMS m/z 318 [M]+; positive HREIMS m/z 318.0883 
[M]+ (calcd for C20H14O4, 318.0892). 
 
2-Methoxy-9-(3′-methoxy-4′-hydroxyphenyl)-1H-
phenalen-1-one (10): red powder; UV (MeOH) λmax ( log ε) 
412 (2.87), 365 (2.93), 262 (3.36), 217 (3.55) nm; IR (KBr) 
νmax 3424, 1724, 1629, 1276 cm−1; 1H and 13C NMR data, see 
Table 3; positive EIMS m/z 332 [M]+; positive HREIMS m/z 
332.1046 [M]+ (calcd for C21H16O4, 332.1049). 
 
trans-(1S,2S)-3-(4′-Methoxyphenyl)-acenaphthene-1,2-
diol (13): colorless, amorphous powder; [α]20D − 22.7 (c 0.10, 
MeOH); UV (MeOH) λmax (log ε) 293 (3.37), 265 (3.78), 222 
(3.79) nm; IR (KBr) νmax 3431, 2922, 1630, 1460, 1249, 1033 
cm−1; 1H and 13C NMR data, see Table 3; positive ESIMS m/z 
315 [M + Na]+; positive HRESIMS m/z 315.0990 [M + Na]+ 
(calcd for C19H16O3Na, 315.0997). 
 
1,2′,3′,4′,6′-O-Pentaacetyl-3-O-trans-p-coumaroylsucrose 
(16): colorless, amorphous powder; [α] 20D  + 42.5 (c 0.25, 
MeOH); UV (MeOH) λmax (log ε) 316 (3.73), 229 (3.41), 211 
(3.38) nm; IR (KBr) νmax 3440, 1723, 1630, 1244, 1050 cm−1; 
1H and 13C NMR data, see Table 4; negative ESIMS m/z 697 
[M − H]; negative HRESIMS m/z 697.1960 [M − H] (calcd 
for C31H37O18, 697.1979). 
 
1,2′,3′,4′,6′-O-Pentaacetyl-3-O-cis-p-coumaroylsucrose 
(17): colorless, amorphous powder; [α] 20D  − 15.3 (c 0.10, 
MeOH); UV (MeOH) λmax (log ε) 315 (3.59), 211 (3.39) nm; 
IR (KBr) νmax 3433, 1751, 1630, 1236, 1046 cm−1; 1H and 13C 
NMR data, see Table 4; negative ESIMS m/z 697 [M − H]; 
negative HRESIMS m/z 697.1980 [M − H] (calcd for 
C31H37O18, 697.1979). 
 
Alkaline Hydrolysis of 16. A mixture of 16 (5.0 mg), 0.5% 
NaOH (0.5 ml), and MeOH (3 ml) was stirred at room temper-
ature for 6 h. The reaction mixture was neutralized with 1 N 
HCl and extracted with CHCl3 (3 × 10 ml). The aqueous layer 
was evaporated to dryness. The dry powder was chromatog-
raphyed over silica gel CC, eluted with CHCl3-MeOH-H2O 
(35:25:2), to furnish sucrose (1.5 mg). Sucrose: [α]20D + 38.3 (c 
0.10, H2O); negative ESIMS m/z 377 [M + Cl]−. 
 
Cytotoxicity Assay. Cytotoxicity of selected compounds 
against HL-60, SMMC-7721, A-549, MCF-7, and SW480 cell 
lines was assessed using the MTT method.22 Cells were plated 
in 96-well plates 12 h before treatment and continuously ex-
posed to different concentrations of compounds. After 48 h, 20 
μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) solution were added to each well, which were 
incubated for another 4 h. Then 20% SDS (100 μL) were add-
ed to each well. After 12 h at room temperature, the OD value 
of each well was recorded at 595 nm. The IC50 value of each 
compound was calculated by the Reed and Muench method.23 
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